Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 42, 2010 - Issue 11-12
Submit an article Journal homepage
800
Views
94
CrossRef citations to date
0
Altmetric
Research Article

Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea

Kjetil Garborg Department of Medicine, Sørlandet Hospital HF KristiansandCorrespondence[email protected]
,
Bjørn Waagsbø Department of Infectious Diseases, St. Olavs University Hospital, Trondheim
,
Asbjørn Stallemo Department of Medicine, Sørlandet Hospital HF Kristiansand
,
Jon Matre Department of Medicine, Sørlandet Hospital HF Kristiansand
&
Anders Sundøy Vognsneset 50, 4640 Søgne, Norway
Pages 857-861 | Received 04 Feb 2010, Accepted 05 Jun 2010, Published online: 22 Jul 2010

References

  • Gerding DN, Muto CA, Owens RC. Treatment of Clostridium difficile infection. Clin Infect Dis 2008;46(Suppl 1): S32–42.
  • Kuipers EJ, Surawicz CM. Clostridium difficile infection. Lancet 2008;371:1486–8.
  • Kelly CP, LaMont JT. Clostridium difficile—more difficult than ever. N Engl J Med 2008;359:1932–40.
  • Leffler DA, Lamont JT. Treatment of Clostridium difficile-associated disease. Gastroenterology 2009;136:1899–912.
  • Monaghan T, Boswell T, Mahida YR. Recent advances in Clostridium difficile-associated disease. Postgrad Med J 2009;85:152–62.
  • Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, . Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005; 40:1591–7.
  • Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect 2009; 58:403–10.
  • van Nood E, Speelman P, Kuijper EJ, Keller JJ. Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill 2009;14:pii:19316.
  • Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003;36:580–5.
  • Fløtterød O, Hopen G. [Refractory Clostridium difficile infection. Untraditional treatment of antibiotic-induced colitis]. Tidsskr Nor Laegeforen 1991;111:1364–5.
  • Lund-Tønnesen S, Berstad A, Schreiner A, Midtvedt T. [Clostridium difficile-associated diarrhea treated with homologous feces]. Tidsskr Nor Laegeforen 1998;118:1027–30.
  • Schwan A, Sjölin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983;2:845.
  • Schwan A, Sjölin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984;16:211–5.
  • Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989;1:1156–60.
  • Persky SE, Brandt LJ. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol 2000;95:3283–5.
  • Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007;142:624–31; discussion 631.
  • Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, . Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466–72.
  • McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 2006;12: 409–15.
  • Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998;40:1–15.
  • Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008;46(Suppl 1):S19–31.
  • Garey KW, Sethi S, Yadav Y, DuPont HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008;70:298–304.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.